| Number of patients (%) |
---|---|
Patients who completed the treatment | 84 (100%) |
Fractionation scheme | |
 15 × 2.67 Gy | 62 (73.8%) |
 20 × 2.67 Gy (simultaneously integrated boost (SIB)) | 22 (26.2%) |
Radiotherapy | |
 Whole-breast | 60 (71.4%) |
 Chest wall | 24 (28.6%) |
Treatment volume | |
 Axillary lymph nodes level 1–2 | 22 (26.2%) |
 Axillary lymph nodes level 3–4 | 23 (27.4%) |
 Axillary lymph nodes level 1–4 | 22 (26.2%) |
 | With SIB | Without SIB |
---|---|---|
Local | 12 (14.3%) | 5 (6.0%) |
Locoregional, without internal Mammary lymph nodes (IMN) | 9 (10.7%) | 46 (54.8%) |
Locoregional, with IMN | 1 (1.2%) | 11 (13.1%) |
Age at start treatment (years) | ||
 Mean ± SD | 55 ± 10 years | |
 Median (range) | 55 years (35–77 years) |